Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
12/2005
12/08/2005US20050272802 Process for preparing form I of tegaserod maleate
12/08/2005US20050272800 NK1 antagonists
12/08/2005US20050272797 Processes for preparation of bicyclic compounds and intermediates therefor
12/08/2005US20050272788 Indoles having anti-diabetic activity
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272661 providing a neo-tryptophan derivative, andlinking amino acid residues to said neo-tryptophan derivative to form neurotensin polypeptide containing neo-tryptophan
12/08/2005US20050272036 Ketones
12/08/2005US20050271592 Optical diagnostic and therapeutic agents and compositions
12/08/2005DE102004023632A1 Substituierte Cyclohexylcarbonsäure-Derivate Substituted cyclohexyl carboxylic acid derivatives
12/08/2005CA2568050A1 Indazole and indolone derivatives and their use as pharmaceuticals
12/07/2005EP1602646A1 Processes for producing cyclic benzamidine derivative
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1602373A1 Ocular hypotensive agent
12/07/2005EP1601651A1 Process for the preparation of 1,1,3,3-tetraalkylisoindolines starting from n-benzylphthalimide
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1171442B1 Xanthine derivatives and analogs as cell signalling inhibitors
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP0949920B1 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of alzheimer's disease and dementias
12/07/2005CN1705635A Inhibitors of histone deacetylase
12/07/2005CN1705480A 4-piperazinyl benzenesulfonyl indoles with 5-HT6 receptor affinity
12/07/2005CN1704401A Pharmaceutical use of 1-N-methoxy-2-oxo-indole-3-acetamide
12/07/2005CN1230432C Substituted phenyl-Piperazine derivatives, their preparation and use
12/07/2005CN1230423C 1,4-disubstituted piperazine derivatives useful as uro-selective dollar g(a)1-adrenoceptor blockers
12/07/2005CN1230418C Selective androgen receptor modulators and methods of use thereof
12/07/2005CN1230416C Pharmaceutical compounds
12/07/2005CN1230163C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
12/06/2005US6972340 For therapy of diabetes, obesity, autoimmune disorders, acute and chronic inflammatory disorders, osteoporosis, cancer, malignant disorders
12/06/2005US6972336 N-alkylation of indole derivatives
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972287 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits
12/06/2005CA2303244C Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
12/06/2005CA2268910C Asymmetrical imide bleach activators and compositions employing the same
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/06/2005CA2163115C N-substituted beta-aryl- and beta-heteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
12/01/2005WO2005113646A1 Deuterated polyimides and derivatives thereof
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005WO2005113537A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113502A1 Process for the preparation of carvedilol
12/01/2005WO2005113501A1 Neurogenic pain control agent composition
12/01/2005WO2005113500A1 Process for the preparation of perindopril and salts thereof
12/01/2005WO2005113499A1 Indole compounds
12/01/2005WO2005113498A1 Adrenergic receptor antagonists
12/01/2005WO2005113011A2 Prodrugs of ion channel modulating compounds and uses thereof
12/01/2005WO2005112945A2 Synthesis of tetracyclines and analogues thereof
12/01/2005WO2005112640A2 Compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases
12/01/2005WO2005077899A3 Amino-substituted tricyclic derivatives and methods of use
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005WO2005023196A3 Compounds and methods
12/01/2005WO2004080964A8 Indole derivatives useful for the treatment of diseases
12/01/2005US20050267304 Protein kinase inhibitors; astham; psoriasis; antiinflammatory agents; inflammatory bowel disorders
12/01/2005US20050267196 Reducing tumor necrosis factor; phosphodiesterase inhibitor; anticancer agents; antidepressants; antiinflammatory agents; skin dsorders; antidepressants
12/01/2005US20050267194 Indole compounds
12/01/2005US20050267191 Process for producing a dipeptidyl peptidase IV inhibitor
12/01/2005US20050267184 3-Aminocarbonyl substituted benzoylpyrazolones
12/01/2005US20050267173 Serine protease inhibitors
12/01/2005US20050267171 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050267111 Pharmaceutical compositions and methods for use
12/01/2005US20050267108 Treatment of peroxisome proliferation activated receptor diseases such as diabetes, skin disorders or high blood pressure
12/01/2005US20050267107 4-alkyl-/4-alkenyl-/4-alkynyl methyl/-1-aryl-cyclohexylamine compounds
12/01/2005US20050267043 Novel inhibitors of hepatitis C virus NS3 protease
12/01/2005US20050266520 Process for the synthesis of peptides
12/01/2005US20050266329 Organophotoreceptor comprises an electrically conductive substrate and a photoconductive element; electrophotography
12/01/2005DE102004023522A1 Substituierte Cyclohexyl-1,4-diamin-Derivate Substituted cyclohexyl-1,4-diamine derivatives
12/01/2005DE102004023507A1 Substituierte Cyclohexylessigsäure-Derivate Cyclohexylacetic substituted derivatives
12/01/2005CA2567487A1 Deuterated polyimides and derivatives thereof
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2566197A1 Process for the preparation of carvedilol
12/01/2005CA2566062A1 Treatment or prevention of respiratory viral infections with immunomodulator compounds
12/01/2005CA2563968A1 Neurogenic pain control agent composition
12/01/2005CA2561819A1 Prodrugs of ion channel modulating compounds and uses thereof
11/2005
11/30/2005EP1600821A1 Bridged charge transport materials having a central sulfur atom linkage
11/30/2005EP1599470A1 Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them
11/30/2005EP1599446A1 An improved process for the preparation of gabalactam
11/30/2005EP1599438A1 Preparation of substituted phthalic anhydride, especially 4-chlorophtalic anhydride
11/30/2005EP1511385B1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
11/30/2005EP1465892A4 Glycinamides as factor xa inhibitors
11/30/2005EP1274457B1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
11/30/2005EP1098864B9 Method for hydrogenating unsaturated heterocyclic compounds
11/30/2005EP0925291B1 Spirocyclic dopamine receptor subtype ligands
11/30/2005EP0920424B1 Non-peptide bombesin receptor antagonists
11/30/2005EP0888341B1 Novel sulphur derivatives comprising an amide bond, method for preparing same, use thereof as drugs, and pharmaceutical compositions containing such derivatives
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1703397A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
11/30/2005CN1702563A Bridged charge transport materials having a central sulfur atom linkage
11/30/2005CN1702066A Hole transport materials with 9-phenyl carbazole as core and process for making same
11/30/2005CN1702065A Fluorene-based compound and organic electroluminescent display device using the same
11/30/2005CN1701814A F1K-1 is a receptor for vascular endothelial growth factor
11/30/2005CN1229377C Spiro [Piperidine-4,1'-pyrrolo[3,4-c] pyrrole]
11/30/2005CN1229362C Bicyclic guanidine derivatives and therapeutic uses thereof
11/30/2005CN1229351C Heterocyclic compounds and methods to treat cardiac failure and other disorders
11/30/2005CN1229345C N-(indolcarbonyl) piperazin derivatives
11/30/2005CN1229343C Chemotactic factor receptor active regulator
11/30/2005CN1229330C N-arylating method using amino-acid as additives
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/30/2005CN1229314C Obtaining anthracene and carbazole by melt-crystallization
1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 458